AVANOS Aktie

>AVANOS Aktienkurs

12.2 EUR +0.0% (TradegateBSX)

Ask: 12.1 EUR / 1240 Stück

Bid: 12 EUR / 1250 Stück

Tagesumsatz: 800 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

AVANOS Aktie über LYNX handeln

Intraday

1 Jahr

>AVANOS Performance

1 Woche: +3,8%

1 Monat: +1,2%

3 Monate: +27,7%

6 Monate: +20,2%

1 Jahr: -4,3%

laufendes Jahr: +26,8%

>AVANOS Aktie

Name:

AVANOS MEDICAL INC.DL-,01

Land:

USA

Sektor:

Gesundheit

ISIN/ Wkn:

US05350V1061 / A2JNRG

Symbol/ Ticker:

8HH (Frankfurt) / AVNS (NYSE)

Kürzel:

FRA:8HH, ETR:8HH, 8HH:GR, NYSE:AVNS

Index:

Webseite:

https://avanos.com/

Profil:

Avanos Medical Inc. is a healthcare company specializing in the development and production of medical devices designed to improve patient outcomes and reduce procedural costs. Primarily focusing on chronic care and pain management solutions, Avanos M..
>Volltext..

Marktkapitalisierung:

562 Mio. EUR

Unternehmenswert:

596.05 Mio. EUR

Umsatz:

607.46 Mio. EUR

EBITDA:

59.6 Mio. EUR

Nettogewinn:

-63.15 Mio. EUR

Gewinn je Aktie:

-1.36 EUR

Schulden:

111.84 Mio. EUR

Liquide Mittel:

77.8 Mio. EUR

Operativer Cashflow:

64.71 Mio. EUR

Bargeldquote:

0.54

Umsatzwachstum:

1.95%

Gewinnwachstum:

81.41%

Dividende je Aktie:

Dividendenrendite:

Dividendenschätzung:

Insiderhandel:

Suchwörter:

AVANOS

Letzte Datenerhebung:

05.04.26

>AVANOS Kennzahlen

Aktien/ Unternehmen:

Aktien: 46.5 Mio. St.

Frei handelbar: 96.2%

Leerverk. Aktien: 5.02%

Rückkaufquote: 0.4%

Mitarbeiter: 2287

Umsatz/Mitarb.: 0.27 Mio. EUR

Analysten:

Analystenrating: Neutral

Kursziel: -

Bewertung:

KGV: -

KGV lG: 13.95

KUV: 0.93

KBV: 0.83

PEG-Ratio: -

EV/EBITDA: 10

Rentabilität:

Bruttomarge: 49.77%

Gewinnmarge: -10.4%

Operative Marge: 4.26%

Managementeffizenz:

Gesamtkaprendite: -6.54%

Eigenkaprendite: -9.07%

>AVANOS Peer Group

Gesundheit, Medizinprodukte & -technik/ Implantate/ Wundpflege

>AVANOS Chart & Kurs - NYSE

>AVANOS News

19.03.26 - 17:15	Reasons to Retain Avanos Medical Stock in Your Portfolio for Now (Zacks)
	AVNS gains on strong SNS and PMR growth, M&A and cost actions, but tariff risks and segment headwinds may weigh on near-term performance....

17.03.26 - 13:48	SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Avanos Medical, Inc. (NYSE: AVNS) (PR Newswire)
	NEW YORK, March 17, 2026 /PRNewswire/ -- Purcell & Lefkowitz LLP announces that it is investigating Avanos Medical, Inc. (NYSE: AVNS) on behalf of the company's shareholders. The investigation seeks to determine whether Avanos Medical's directors breached their fiduciary duties in......

02.03.26 - 23:30	Avanos Medical, Inc. to Present at the 2026 Citizens Life Sciences Conference (PR Newswire)
	ALPHARETTA, Ga., March 2, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Dave Pacitti, chief executive officer, and Scott Galovan, senior vice president and chief financial officer, will participate in a fireside chat at the 2026 Citizens Life Sciences......

26.02.26 - 13:03	Avanos Medical, Inc. to Nominate James Cunniff and William Burke to Board of Directors (PR Newswire)
	Enters into Agreement with Bradley L. Radoff ALPHARETTA, Ga., Feb. 26, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS), a leading medical technology company, today announced that it intends to nominate James ("Jim") L. Cunniff, President and CEO of Electromed, Inc., and William......

25.02.26 - 20:30	Avanos Medical Stock Dips Despite Q4 Earnings Beat, Revenues Up Y/Y (Zacks)
	AVNS shares plunge 10% even after a Q4 earnings and revenue beat, as margin pressure and tariff concerns weigh on investors....

24.02.26 - 18:30	Avanos expects $700M–$720M sales in 2026 as China exit drives tariff mitigation (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

24.02.26 - 16:06	Earnings Call: Avanos Medical übertrifft Prognosen für Q4 2025 – Aktie bricht dennoch ein (Investing.com DE)
	Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

24.02.26 - 13:03	Avanos Medical, Inc. Announces Fourth Quarter and Full-Year 2025 Results (PR Newswire)
	Exceeded full-year revenue and achieved the top end of full-year earnings-per-share guidance Delivered full-year organic growth of 6% in strategic segments Expanded transformation initiatives expected to deliver $15 to $20 million of incremental annualized savings by the end of 2026......

24.02.26 - 13:03	Avanos Medical Non-GAAP EPS of $0.29, revenue of $180.9M (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

23.02.26 - 18:00	Avanos Medical Q4 2025 Earnings Preview (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

16.02.26 - 22:33	Avanos Medical, Inc. to Webcast Conference Call Discussing Fourth Quarter and Full Year 2025 Financial Results (PR Newswire)
	ALPHARETTA, Ga., Feb. 16, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the fourth quarter and full year 2025 on Tues., Feb. 24 at 9 a.m., ET. The company will issue a news release detailing......

29.01.26 - 21:15	Reasons to Retain Avanos Medical Stock in Your Portfolio Now (Zacks)
	AVNS shows solid 3Q25 momentum from SNS and PMR growth, aided by M&A and cost cuts, even as tariffs and FX volatility linger....

26.01.26 - 18:15	AVNS & Siemens Healthineers Team Up on Advanced Integrated Pain Care (Zacks)
	Avanos Medical teams up with an imaging partner to pair RFA with mobile imaging, targeting the shift of complex pain procedures to outpatient care....

08.01.26 - 02:27	Avanos Medical, Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference (PR Newswire)
	ALPHARETTA, Ga., Jan. 7, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Dave Pacitti, chief executive officer, will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, California, on Tuesday, Jan. 13, at approximately 2:15 p.m. PST.......

05.12.25 - 19:00	Why Is Avanos Medical (AVNS) Down 0.5% Since Last Earnings Report? (Zacks)
	Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues....

19.11.25 - 22:02	Insiderhandel: SVP, Chief Commercial Officer verkauft Aktien von Avanos Medical im Wert von 165015 USD (Insiderkauf)
	Holbrook, Kerr - Vorstand - Tag der Transaktion: 2025-11-18...

06.11.25 - 18:24	Avanos Medical (AVNS) Q3 2025 Earnings Transcript (Fool)
	Um den gesamten Artikel unter fool.com zu lesen, klicken Sie bitte auf die Überschrift...

06.11.25 - 16:00	Avanos Medical Gains on Q3 Earnings Beat, Raises ′25 Sales View (Zacks)
	Avanos Medical posts a Q3 earnings and sales beat, boosts 2025 outlook as Specialty Nutrition drives solid double-digit growth....

05.11.25 - 16:00	Avanos Medical (AVNS) Q3 Earnings and Revenues Beat Estimates (Zacks)
	Avanos Medical (AVNS) delivered earnings and revenue surprises of +37.50% and +6.88%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?...

05.11.25 - 13:27	Avanos Medical Non-GAAP EPS of $0.22 beats by $0.10, revenue of $177.8M beats by $13.3M (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Notwendigkeit ist bei weitem stärker als die Kunst. - Aischylos

Partner: >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram